Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
Authors
Keywords
BRAF V600E mutation, Tissue microarray, Brain tumor, Cerebral metastases, Epithelioid glioblastoma, Glioblastoma, Gliosarcoma, Rhabdoid meningioma
Journal
Diagnostic Pathology
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-27
DOI
10.1186/s13000-016-0506-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A clinicopathologic study of diencephalic pediatric low-grade gliomas with BRAF V600 mutation
- (2015) Cheng-Ying Ho et al. ACTA NEUROPATHOLOGICA
- BRAF VE1 Immunoreactivity Patterns in Epithelioid Glioblastomas Positive for BRAF V600E Mutation
- (2015) Bette K. Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma
- (2015) E. Tabouret et al. EJSO
- Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549–BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification
- (2015) Midea Gierke et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One WithBRAFV600EMutation and Clinical Response to theBRAFInhibitor Dabrafenib
- (2015) Aisulu Usubalieva et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Next-generation (epi)genetic drivers of childhood brain tumours and the outlook for targeted therapies
- (2015) Paul A Northcott et al. LANCET ONCOLOGY
- Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing
- (2015) J. S. Estrella et al. MOLECULAR CANCER THERAPEUTICS
- Diagnostic, prognostic and predictive relevance of molecular markers in gliomas
- (2015) Sebastian Brandner et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- BRAF V600E mutation-specific antibody: A review
- (2015) Lauren L. Ritterhouse et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- VE1 Antibody Immunoreactivity in Normal Anterior Pituitary and Adrenal Cortex Without Detectable BRAF V600E Mutations
- (2014) Daniel A. Mordes et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
- (2014) Giles W Robinson et al. BMC CANCER
- Analysis of KIAA1549–BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas
- (2014) Gabriela Rampazzo Cruz et al. JOURNAL OF NEURO-ONCOLOGY
- Immunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma
- (2014) Katerina Dvorak et al. PATHOLOGY
- Pilomyxoid astrocytoma treated successfully with vemurafenib
- (2014) Mary Skrypek et al. PEDIATRIC BLOOD & CANCER
- Metastatic Rhabdoid Meningioma withBRAFV600E Mutation and Good Response to Personalized Therapy: Case Report and Review of the Literature
- (2014) Oz Mordechai et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors
- (2014) Jacquelyn J. Roth et al. Cancer Genetics
- VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
- (2013) Jan Sperveslage et al. ACTA NEUROPATHOLOGICA
- BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma
- (2013) Sonika Dahiya et al. ACTA NEUROPATHOLOGICA
- Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
- (2013) Bette Kay Kleinschmidt-DeMasters et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non-Small Cell Lung Cancer
- (2013) S. Cardarella et al. CLINICAL CANCER RESEARCH
- Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization
- (2013) Shih-Fan Kuan et al. HUMAN PATHOLOGY
- Brainstem Ganglioglioma Successfully Treated With Vemurafenib
- (2013) Sarah Rush et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series
- (2013) Marc C. Chamberlain JOURNAL OF NEURO-ONCOLOGY
- Rethinking the war on cancer
- (2013) Douglas Hanahan LANCET
- Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK
- (2013) H. Vin et al. MOLECULAR CANCER THERAPEUTICS
- Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
- (2013) NATURE GENETICS
- Vemurafenib in pediatric patients withBRAFV600Emutated high-grade gliomas
- (2013) Francisco Bautista et al. PEDIATRIC BLOOD & CANCER
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1
- (2013) L. A. Ramkissoon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- No Evidence for BRAF-V600E Mutations in Gastroeosophageal Tumors
- (2013) Matthias Preusser et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- EGFR,KRAS,BRAF, andHER-2molecular status in brain metastases from 77 NSCLC patients
- (2013) Claire Villalva et al. Cancer Medicine
- Immunohistochemistry is highly sensitive and specific for detection of BRAF V600E mutation in pleomorphic xanthoastrocytoma
- (2013) Cristiane M Ida et al. Acta Neuropathologica Communications
- Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients
- (2012) M. Ilie et al. ANNALS OF ONCOLOGY
- TheBRAFV600EMutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study
- (2012) Rossella Elisei et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Detection of BRAF p.V600E Mutations in Melanomas
- (2012) Emeline Colomba et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy
- (2012) M Colombino et al. Cell Death & Disease
- Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody
- (2011) David Capper et al. ACTA NEUROPATHOLOGICA
- Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
- (2011) Genevieve Schindler et al. ACTA NEUROPATHOLOGICA
- Targeted Therapy for BRAFV600E Malignant Astrocytoma
- (2011) T. P. Nicolaides et al. CLINICAL CANCER RESEARCH
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation